PolyNovo Company Description

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China.

The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products.

The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014.

PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

PolyNovo Limited

Country	Australia
Founded	1998
Industry	Medical Devices
Sector	Healthcare
Employees	301
CEO	Bruce Peatey

Contact Details

Address: 320 Lorimer Street Port Melbourne, VIC 3207 Australia
Phone	61 3 8681 4050
Website	polynovo.com

Stock Details

Ticker Symbol	PNV
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000PNV0
SIC Code	3842

Key Executives

Name	Position
Bruce Peatey	Chief Executive Officer
Jan-Marcel Gielen C.A.	Chief Financial Officer and Company Secretary
Dr. Marthe D'Ombrain	Chief Scientific Officer
Amy Demediuk	Company Secretary and General Counsel
Kimberley Axon	Chief People Officer
Edward Graubart	President of North America
Ahmed Hassan	Chief Manufacturing and Supply Chain Officer